Corrigendum to: “The Role of Colchicine in Different Clinical Phenotypes of Behcet's Disease” [Clin Therapeut 45(2) (2023) 162–176]

Colchicine reduces the severity of certain clinical phenotypes and may improve the overall disease activity index in patients with BD. More randomized clinical trials are needed to confirm the value of colchicine in the treatment of BD, and further elucidation of the mechanisms is also needed, which may reveal new application of colchicine that has been used for centuries.